BiotechTube
Home/HotSpot Therapeutics/Jonathan Montagu
JM

Jonathan Montagu

Chief Executive Officer

HotSpot Therapeutics

Therapeutic Areas

Autoimmune DiseasesOncology

HotSpot Therapeutics Pipeline

DrugIndicationPhase
IRF5 InhibitorAutoimmune diseases (e.g., Lupus)Preclinical